↓ Skip to main content

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials

Overview of attention for article published in BMC Cancer, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user
reddit
1 Redditor

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials
Published in
BMC Cancer, March 2022
DOI 10.1186/s12885-022-09444-0
Pubmed ID
Authors

Pengfei Zhao, Hongchao Zhen, Hong Zhao, Lei Zhao, Bangwei Cao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 12%
Student > Master 2 8%
Student > Postgraduate 2 8%
Student > Bachelor 1 4%
Other 1 4%
Other 2 8%
Unknown 14 56%
Readers by discipline Count As %
Medicine and Dentistry 4 16%
Unspecified 3 12%
Biochemistry, Genetics and Molecular Biology 2 8%
Linguistics 1 4%
Business, Management and Accounting 1 4%
Other 2 8%
Unknown 12 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2023.
All research outputs
#1,969,158
of 23,975,876 outputs
Outputs from BMC Cancer
#314
of 8,557 outputs
Outputs of similar age
#46,474
of 444,258 outputs
Outputs of similar age from BMC Cancer
#6
of 281 outputs
Altmetric has tracked 23,975,876 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,557 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,258 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 281 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.